Similar articles

• [The metabolic syndrome and chronic vascular disease. Cellular mechanisms and potential candidate genes].

  Haller H, Knoblauch H, Schuster H, Luft FC. Haller H, et al. Internist (Berl). 1996 Jul;37(7):687-97. Internist (Berl). 1996. PMID: 8766262 Review. German. No abstract available.
• The insulin resistance syndrome.

  Smolar EN. Smolar EN. Compr Ther. 1997 Apr;23(4):237-43. Compr Ther. 1997. PMID: 9167914 Review. No abstract available.
• Insulin resistance: the clinical spectrum.

  Mantzoros CS, Flier JS. Mantzoros CS, et al. Adv Endocrinol Metab. 1995;6:193-232. Adv Endocrinol Metab. 1995. PMID: 7671097 Review. No abstract available.
• [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].

  Pedersen O. Pedersen O. Ugeskr Laeger. 1992 May 11;154(20):1411-8. Ugeskr Laeger. 1992. PMID: 1631967 Review. Danish.
• The deadly quartet--the insulin resistance syndrome.

  Opara JU, Levine JH. Opara JU, et al. South Med J. 1997 Dec;90(12):1162-8. South Med J. 1997. PMID: 9404899 Review.